| Net income | 2.68M |
| Amortization of premiums and discounts on securities, net | -1K |
| Depreciation and amortization | 601K |
| Amortization of intangible asset | 0 |
| Expense related to share based compensation plans | 103K |
| Expense related to ESOP | 165K |
| Provision for loan losses | 307K |
| Provision for losses on foreclosed real estate | 6K |
| Increase in value of bank-owned life insurance | -233K |
| BOLI benefit in excess of surrender value | |
| Gain on sale of securities | -68K |
| Gain on sale of loans | |
| Proceeds from sale of loans | 3.36M |
| Loans originated for sale | -3.29M |
| Loss on sale of foreclosed assets | 10K |
| Amortization of mortgage servicing rights | 9K |
| Net change in accrued interest receivable and other assets | |
| Net change in accrued expenses and other liabilities | |
| Net cash provided by operating activities | |
| Maturities, prepayments and calls | 23.83M |
| Purchases | -21M |
| Maturities, prepayments and calls | 0 |
| Proceeds from sale of held-to-maturity securities | |
| Proceeds from sale of available for sale securities | 0 |
| Net change in loans | -21.25M |
| Net change in certificates of deposit in other financial institutions | |
| Purchases of premises and equipment | -1.96M |
| Proceeds from sale of foreclosed assets | 70K |
| Net cash provided by investing activities | |
| Net change in deposits | 4.49M |
| Net change in short-term borrowings | |
| Net change in long-term borrowings | |
| Shares purchased for deferred compensation plan | |
| Proceeds from purchase of shares by Dividend Reinvestment Plan | |
| Cash dividends paid on common stock | |
| Net cash used in financing activities | |
| Increase in Cash and Cash Equivalents | 546K |
| Cash and Cash Equivalents, Beginning of Period | 12.7M |
| Cash and Cash Equivalents, End of Period | 13.25M |
| Interest paid on deposits and borrowings | 1.36M |
| Federal income taxes paid | 1.01M |
| Transfers from loans to foreclosed assets held for sale | |
| Unrealized gains on securities designated as available for sale, net of related tax effects | |
| Trade date securities purchases | |